ID   K1735-C4.S2-3
AC   CVCL_E7ZJ
SY   C4.S2.3
RX   PubMed=7535333;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97361; Nos2 (Note=With p.Ser1113_Leu1144 replaced with ASVLLNPQNN; inactive).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E7ZF ! K1735-C4
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=7535333; DOI=10.1084/jem.181.4.1333; PMCID=PMC2191958;
RA   Xie K.-P., Huang S.-Y., Dong Z.-Y., Juang S.-H., Gutman M., Xie Q.-W.,
RA   Nathan C.F., Fidler I.J.;
RT   "Transfection with the inducible nitric oxide synthase gene suppresses
RT   tumorigenicity and abrogates metastasis by K-1735 murine melanoma
RT   cells.";
RL   J. Exp. Med. 181:1333-1343(1995).
//